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Summary objectives To synthesise data from four recent studies in Tanzania examining maternal syphilis
screening and its operational implementation in routine antenatal clinics (ANC), drawing lessons for
strengthened antenatal services for the prevention of mother-to-child transmission (PMTCT) of HIV.
methods The impact of untreated maternal syphilis was examined in a retrospective cohort of 380
Tanzanian women. Effectiveness and cost-effectiveness of screening and single dose benzathine penicillin
treatment were prospectively examined in 1688 pregnant women. Observation, interviews and facility
audits were carried out in health facilities within nine districts to determine the operational reality of
syphilis screening.
results Overall, 49% of women with untreated high titre syphilis experienced an adverse pregnancy
outcome compared with 11% of uninfected women. Stillbirth and low birthweight rates among those
treated for high- or low-titre syphilis were reduced to rates similar to those for uninfected women. The
economic cost was $1.44 per woman screened and $10.56 per disability-adjusted life year saved. In the
operational study, only 43% of 2256 ANC attenders observed were screened and only 61% of sero-
reactive women and 37% of their partners were treated. Adequate training, continuity of supplies,
supervision and quality control are critical elements for strengthened antenatal services, but are fre-
quently overlooked.
conclusions Maternal syphilis has a severe impact on pregnancy outcome. Same-day screening and
treatment strategies are clinically effective and highly cost-effective, but there are significant challenges
to implementing syphilis screening programmes in sub-Saharan Africa. Current PMTCT interventions
present an opportunity to reinforce and improve syphilis screening. Increasing PMTCT coverage will
involve similar operational challenges to those faced by syphilis screening programmes.
keywords antenatal clinics, syphilis screening, adverse pregnancy outcomes, prevention of mother to
child transmission of HIV, cost-effectiveness, barriers, operational implementation, Tanzania, Africa
Introduction
With the global focus on the impact of the HIV/AIDS
epidemic in many parts of the developing world, antenatal
care policy and recent intervention studies have largely
addressed the prevention of mother-to-child transmission
(PMTCT) of HIV (Walker et al. 2002; Jackson et al. 2003;
Stringer et al. 2003). However, the impact of other
antenatal infections on pregnancy outcomes should not be
forgotten. Syphilis seropositivity in sub-Saharan Africa is
common, with up to 17% of pregnant African women
attending antenatal clinics (ANC) having serological
syphilis (Ratnam et al. 1982; Schultz et al. 1987; Guinness
et al. 1988; Hira et al. 1990; Vuylsteke et al. 1993; Bam
et al. 1994; Leroy et al. 1995; Mayaud et al. 1995, 1998;
Qolohle et al. 1995; Mwakagile et al. 1996; Wilkinson
et al. 1997). Maternal syphilis, left untreated, can have an
impact on the developing foetus as devastating as that of
maternal HIV infection. Maternal syphilis was found to be
responsible for 26 and 42% of stillbirths in unscreened
women in Malawi and Zambia, respectively, and 19% of
spontaneous abortions after 20 weeks of gestation
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(McDermott et al. 1993). Therefore, screening and treat-
ment for syphilis has been recommended as a routine part
of antenatal care (World Health Organisation 2001;
Centers for Disease Control and Prevention 2002).
Management of maternal syphilis relies on serological
screening in pregnancy and treatment with an injectable
penicillin. The recommended treatment for primary, sec-
ondary and early latent syphilis infection is a single
intramuscular dose of 2.4 million units (MU) benzathine
penicillin, with three doses for late latent syphilis or
syphilis of unknown duration (World Health Organisation
2001; Centers for Disease Control and Prevention 2002).
However, there have been many problems with the
practical implementation of these screening and treatment
strategies in developing countries (Gloyd et al. 2001). First,
often for practical reasons, the single dose regimen is
implemented as the standard treatment for all stages of
syphilis, although there are no data from randomized trials
to support the effectiveness of either the single or multiple
dose strategies. Secondly, there are limited data on the cost-
effectiveness (CE) of various screening and treatment
strategies in developing countries to guide policy-makers.
Thirdly, there is little documentation of the operational
challenges faced in the implementation of syphilis screen-
ing and treatment in order to implement it effectively.
Thus, not surprisingly, there has been widespread failure to
implement routine antenatal syphilis screening policies in
many countries. A recent study found that syphilis testing
was a routine part of antenatal care management in 17 of
22 (73%) countries in sub-Saharan Africa, but that in these
17 countries only 38% of pregnant women were actually
screened (Gloyd et al. 2001).
To address these limitations, a recent paper called for
multilevel assessments at national level of the opportunities
for, and barriers to, effective implementation of antenatal
syphilis screening (Hawkes et al. 2004). Responding to this
call, we draw together data from several recent studies in
Tanzania on syphilis in pregnancy in order to estimate the
impact of untreated maternal syphilis, and the effectiveness
and CE of on-site screening and single dose treatment in
averting adverse pregnancy outcomes (Watson-Jones et al.
2002a, 2002b; Terris-Prestholt et al. 2003). In addition,
operational data on routine implementation of syphilis
screening at the primary healthcare (PHC) level are used to
explore the barriers to wide-scale effective implementation
(Oliff 2002). This paper highlights the challenges facing
policy-makers in Africa trying to scale-up the implemen-
tation of this intervention to a national level; draws
parallels with the situation facing HIV-PMTCT pro-
grammes, which involve similar activities such as screen-
ing, testing, treatment and partner management; and
argues for mutual reinforcement and integration of syphilis
and HIV-PMTCT programmes, thus exploiting the
opportunity offered by increased funding and political
commitment directed at HIV-PMTCT.
Materials and methods
Tanzania is amongst several countries that recommend
single dose benzathine penicillin for the treatment of
pregnant women with syphilis as national policy. In theory,
women can thus be tested and treated on the same day if
on-site syphilis screening at the ANC is operational
(Watson-Jones et al. 2002a). National guidelines stipulate
that syphilis screening should be performed as part of
routine antenatal care in all Tanzanian health facilities,
including dispensaries, with ANC attenders having a
screening test at their first antenatal visit for each
pregnancy (Watson-Jones et al. 2002a). In 1996, on-site
syphilis screening was introduced at the main ANC in
Mwanza city, and from 2000 in the whole of Mwanza
Region, by the Ministry of Health with support from the
African Medical and Research Foundation (AMREF), a
healthcare non-governmental organization. All new
attenders are screened for syphilis using the rapid plasma
reagin (RPR) test. RPR-positive women are treated on the
same day with a single dose of benzathine penicillin
2.4 MU and are given a partner notification slip and
encouraged to send their partners to the clinic for free
treatment.
To examine the effectiveness of this programme, several
studies were carried out from 1997 to 2000. The detailed
methods have been described elsewhere (Watson-Jones
et al. 2002a, 2002b). First, to measure the impact of
untreated maternal syphilis on birth outcomes, a retro-
spective cohort of 380 women admitted for delivery was
recruited from three hospitals in Mwanza Region (Watson-
Jones et al. 2002a). Women who had not been tested for
syphilis during that pregnancy were screened by the RPR
test (Syfacard, Murex Diagnostics, UK). For every RPR-
positive woman recruited, the next two RPR-negative
women admitted were also enrolled. Birth outcomes
[stillbirth, low birthweight (LBW), prematurity, intra-
uterine growth retardation and signs of congenital syphilis]
were compared among (a) women with high-titre syphilis
(HTS), defined as an RPR titre >1:8 and a positive specific
treponemal test [Treponema pallidum agglutination assay
(TPHA) MicrosyphTM-TP 1000, Porton, Cambridge, UK;
or fluorescent treponemal antibody-absorption (FTA-ABS)
assay, Trepo-Spot-IF, Bio-Merieux, France]; (b) women
with other serological stages of syphilis and (c) uninfected
women (negative on both RPR and TPHA) (McDermott
et al. 1993; Larsen et al. 1995). Data were collected on
potential confounders for adverse birth outcome including
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socio-demographic factors, maternal malaria and anaemia,
maternal HIV and other reproductive tract infections.
RPR-positive mothers and their infants were treated after
birth where possible.
Secondly, to examine the effectiveness of antenatal
screening and treatment, a prospective cohort of 1688
ANC attenders was recruited from the main ANC in
Mwanza city (Watson-Jones et al. 2002b). For each RPR-
positive woman enrolled consecutively, the next two RPR-
negative women were also recruited and all were followed
to delivery. Data on pregnancy outcome and potential
confounders were collected as above.
Thirdly, the financial and economic costs of introducing
syphilis screening into routine antenatal care services
were measured and the CE of syphilis screening was
calculated (Terris-Prestholt et al. 2003). CE ratios for
LBW live births and stillbirths averted, and the cost per
disability-adjusted life year (DALY) saved, both including
and excluding stillbirths, were calculated. The CE of the
intervention at different syphilis prevalence rates was
modelled. The CE in Mwanza was compared with other
CE studies of syphilis screening in sub-Saharan Africa as
well as with other antenatal interventions, for which
costs per DALY saved were calculated.
Fourthly, to examine the operational reality of imple-
menting routine syphilis screening in public clinics in
Tanzania, data were gathered in 2000/2001 from nine
health facilities around the country (Oliff 2002). One
facility was randomly sampled from each of three districts
from three regions to represent the varied realities of
health service delivery in Tanzania, with urban, roadside
and rural sites being represented. In Mwanza Region
(north-western Tanzania), one district hospital, one health
centre, and one dispensary were selected; in Dodoma
Region (Central), one district hospital, one health centre,
and one dispensary were selected; and in Morogoro
Region (Eastern), two health centres and one dispensary
were selected. On average, 12–14 days were spent in each
site observing clinical care, conducting interviews with
staff and patients and carrying out systematic audits and
client flow analyses. Data were collected on drug and
diagnostic kit supplies and equipment for syphilis screen-
ing, health education sessions, ANC attendance rates for
the previous four months, and the quality and frequency of
staff training.
Ethics approval
Persons included in this study were self-presenting patients
to routine clinics who accepted recording of their anon-
ymized personal data. RPR-positive mothers and their
infants were treated after birth where possible. The
studies were approved by the ethical committees of the
Medical Research Coordinating Committee of Tanzania
and the London School of Hygiene and Tropical
Medicine.
Results
Impact of untreated maternal syphilis
Untreated maternal syphilis was strongly associated with
adverse birth outcome, especially in women with HTS
(Watson-Jones et al. 2002a). Twenty-five per cent of the
73 women with HTS had a stillbirth compared with 1%
of 233 seronegative women [risk ratio (RR) 18.1,
P < 0.001]. HTS cases were also at higher risk of LBW
and premature live births compared with uninfected
women (adjusted RR 3.3 and 6.1, respectively). No
association was found between other serological stages of
syphilis and adverse birth outcomes. In this population,
where 5.9% of women who had not been screened for
syphilis in pregnancy had HTS, 51% of stillbirths, 24%
of preterm livebirths and 17% of all adverse pregnancy
outcomes in unscreened women were attributable to
HTS. By identifying morbidity only at the time of
delivery, our study may have underestimated the actual
burden related to congenital syphilis, as many women
with earlier stillbirths or miscarriages may not have
attended.
Effectiveness of single-dose benzathine penicillin treatment
From September 1997 to December 1999, 19 878 women
were screened at the main ANC in Mwanza and 1522
(7.7%) were RPR-positive. All RPR-positive women were
treated with a single intramuscular dose of benzathine
penicillin 2.4 MU on the day of screening. In total, 1688
women (556 RPR-positive and 1132 RPR-negative) were
recruited to the cohort and 91% were followed to
delivery.
Single-dose treatment was effective in preventing
adverse outcomes attributable to maternal syphilis. There
were no significant differences in birth outcomes between
women treated for syphilis and seronegative women.
Stillbirth and LBW live births were observed in 2.3 and
6.3% of treated HTS cases, and 2.5 and 9.2% of
seronegative women respectively (Watson-Jones et al.
2002b). Controlling for potential confounders, women
treated for either HTS [odds ratio (OR) 0.76, 95%
confidence interval (CI) 0.4–1.4] or low-titre syphilis (OR
0.95, 95% CI 0.6–1.5) were at no increased risk of
adverse pregnancy outcome compared with uninfected
women. Overall, 37% (203/552) contacts of RPR-positive
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women attended, of whom 42 of 203 (21%) men with
complete serology results were RPR-positive (any titre)
and TPHA-positive (Table 1). Serological status of these
men varied according to the serological status of the
female index case: 32% (16/50) of male partners of HTS
women had evidence of serological syphilis, vs. 23% (23/
101) of male partners of low-titre syphilis (LTS) women,
and 6% (3/52) of male partners of women with biological
false positive RPR tests (P ¼ 0.003) (Table 1).
Cost-effectiveness of syphilis screening and treatment
Syphilis screening in Mwanza was highly cost-effective. In
2001 US$, it was estimated to cost $1.44 per woman
screened, $20 per woman treated and $187 per adverse
birth outcome averted (Terris-Prestholt et al. 2003). The
cost per DALY saved was $110 for cases of LBW averted,
and $10.56 per DALY saved if stillbirths averted were also
included. Costs per DALY saved were calculated from
other published CE studies of syphilis screening from sub-
Saharan Africa (Hira et al. 1990; Jenniskens et al. 1995;
Fonck et al. 2001), by adjusting costs to constant 2001$
and performing a re-analysis of data using the same
methodology as for this effectiveness study (Terris-Pre-
stholt et al. 2003). These ranged from $10.56 to $18.73 per
DALY saved, and studies had originally underestimated the
CE of syphilis screening. Modelling showed that the CE of
syphilis screening was highly dependent on syphilis pre-
valence, but was still cost-effective at a relatively low
seroprevalence of 2% ($33 per DALY saved).
Operational performance of the syphilis screening
programme
Screening. Observations in nine districts in 2000/2001
showed that many facilities were failing to implement
syphilis screening effectively. During clinical observations
of 342 ANC attenders across the nine district study sites,
only 39% were either tested for syphilis, or had been
booked for testing if screening was not underway in the
clinic on the date the women attended. Examination of
clinic registers confirmed the failure to capture a high
proportion of women. Of 2256 ANC attenders eligible for
syphilis screening over 4 months at these sites, only 970
(43%) were documented as receiving an RPR test, of
whom 144 (15%) were RPR-positive. Of these cases, only
88 (61%) were treated and 53 (37%) had a sexual contact
who attended the clinic for treatment (Figure 1).
Management. A lack of test kits and drugs at the time of
the survey was observed. Each vertical programme,
including antenatal care services and family planning, had
its own system for ordering and restocking supplies. This
led to duplication and confusion when requisitioning
stocks. The number of facilities with the minimum supplies
needed to test ANC attenders over 1 week and treat
seroreactive women with benzathine penicillin was
assessed, based on average weekly attendance of ANC
attenders recorded in the clinic register over 4 months, and
the average seroprevalence rate at the clinic. Only three
sites were fully equipped to test and treat their ANC
Table 1 Syphilis serological status of male partners according to the serological status of index pregnant women in Mwanza, Tanzania
Serological syphilis categories
Female index patients*
TPHA pos /
RPR pos >1:8
[HTS] (n ¼ 153)
TPHA pos /
RPR pos <1:8
[LTS] (n ¼ 275)
TPHA neg/
RPR pos
[BFP-RPR] (n ¼ 124) Total (n ¼ 552)
Male partners
Seen and tested 50 (33) 101 (37) 52 (42) 203 (37)
Of whom
TPHA pos/RPR pos >1:8 [HTS] 10 (20) 5 (5) 2 (4) 17 (8.5)
TPHA pos/RPR pos <1:8 [LTS] 6 (12) 18 (18) 1 (2) 25 (12)
TPHA pos/RPR neg [Old] 1 (2) 5 (5) 2 (4) 8 (4)
TPHA neg/RPR pos [BFP-RPR] 4 (8) 10 (10) 10 (19) 24 (12)
TPHA neg/RPR neg [No syphilis] 29 (58) 63 (62) 37 (71) 129 (63.5)
Values are given as n (%).
TPHA, Treponema pallidum haemagglutination assay; RPR, rapid plasma reagin test; HTS, high-titre syphilis; LTS, low-titre syphilis; Old,
past or already treated/cured syphilis; BFP, biological false positive.
* For 27 women with ‘Old syphilis’ (TPHA+/RPR-) and 1056 women with ‘No syphilis’ (TPHA-/RPR-) partners were not sought and
tested.
 Two partners of women with LTS attended but had incomplete syphilis results and have been omitted from total of those ‘seen and
tested’.
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attenders for syphilis. Four sites had insufficient supplies to
perform screening, and four sites did not have enough
drugs (two sites lacked both kits and drugs). Furthermore,
of the five sites with sufficient RPR testing kits, RPR testing
was taking place in only two at the time of the survey.
Condoms were available in sufficient quantities across all
sites but one.
Performance of the health system. Other factors
contributing to the failure to screen eligible women,
including the skills and motivation of healthcare workers
(HCW), are summarized in Table 2. Only 10% of 110
interviewed staff who were consulting with patients and
likely to assess prenatal clients (including nurse midwives,
trained nurses, nursing officers and nurse auxiliaries) had
actually received training in performing the RPR test, and
only two trained staff had ever received refresher training.
Problems in maintaining screening services frequently arose
because staff were absent from duty or had been
transferred to another facility before a replacement had
been trained. Because HCW believed that the pack of test
cards within the RPR kits should be used completely once
opened, like a vaccine vial, they instructed women to
attend on specific days for testing, so negating the same-
day testing and treatment protocol. ANC attenders were
frequently asked to return on yet another day for treatment
because nurses and maternal child health aides, who
comprised 73% of the HCW trained in RPR testing, were
not permitted to diagnose and treat medical conditions.
There was a general lack of understanding among HCW at
all sites about the implications of untreated maternal
syphilis and screening was not perceived as a high priority.
Interviews with senior ANC staff revealed that performing
the RPR test itself was an unpopular, time-consuming task,
requiring one HCW to manually rotate each RPR testing
card for 8 min. At the technical level, procedures for
quality control of RPR screening were not in place at any
of the district sites. RPR antigen vials were stored at room
Table 2 Operational barriers to implementing syphilis screening programme at the primary healthcare level in nine districts of Tanzania
Failure to screen and treat eligible antenatal clinic attenders
Lack of RPR testing kits,
drugs and consumables
Different drug and consumables ordering and supply systems in
Tanzania for ANC, FP, STI programmes:
(i) Burden on HCW,
(ii) Complex and time-consuming,
(iii) Inadequate STI drug supply; drugs ‘borrowed’ from ANC stocks
HCW factors Belief among HCW that syphilis prevention in pregnancy is low priority
Often one person trained in RPR test at each site:
(i) Transferred before a replacement trained,
(ii) No cover for leave/illness,
(iii) No refresher training,
(iv) Lack of understanding of rationale behind screening,
(v) Screening is unpopular and time-consuming
Belief that kits must be used in entirety therefore HCW postpone screening
Lack of HCW trained to give injections preventing same-day treatment
Lack of antibiotic prescribing authority for nurses
Performance and quality of RPR screening
Performance, quality control
and storage
Rate of biological false positive results probably too high
No quality control procedures in place
Storage of RPR test kits inadequate
HCW/health system factors No refresher training of HCW
Lack of adequate supervision of HCW
RPR, rapid plasma regain; ANC, antenatal clinic; FP, family planning; STI, sexually transmitted infections; HCW, healthcare workers.
Figure 1 Proportion of antenatal clinic (ANC) clients tested and
treated for syphilis over 4 months in nine district health facilities in
Tanzania, 2000.
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temperature in all the districts as the Expanded Programme
of Immunization refrigerators were considered to be
reserved for vaccines.
The district health management teams routinely made
quarterly supervision visits to the health facilities. These
were usually administrative visits, rather than providing
technical supervision. There was no supervision of quality
of care and examination of clinic registers showed wide
fluctuations in monthly RPR prevalence rates that were
neither detected nor acted upon during these supervision
visits, despite the fact that they suggested variability in test
performance (Figure 2).
Discussion
Single dose treatment of syphilis is effective and
cost-effective
Maternal syphilis, left untreated, continues to be an
important risk factor for adverse pregnancy outcome in
Tanzania (Watson-Jones et al. 2002b; Terris-Prestholt
et al. 2003). This risk is especially high in mothers with high
RPR test titres, observed in earlier stages of infection
(Watson-Jones et al. 2002a), and is consistent with an
earlier African study (Schultz et al. 1987). There remain no
data from randomized trials comparing single with triple
dose benzathine penicillin therapy, but our data suggest
that single dose treatment is effective in preventing stillbirth
and LBW in women with syphilis, including those with
HTS, the stage of untreated syphilis most strongly associ-
ated with poor birth outcome (Watson-Jones et al. 2002b).
Our cost analysis of syphilis screening and treatment in
Tanzania also shows that this is a highly cost-effective
intervention (Terris-Prestholt et al. 2003). Earlier studies
estimated that the cost of antenatal syphilis screening
compared well with other childhood interventions (Schultz
et al. 1992). In the context of the HIV epidemic in Africa,
the cost of syphilis screening and treatment ($10.56 per
DALY saved) compares favourably to that of nevirapine
treatment for HIV-PMTCT in Uganda ($11.19) (Marseille
et al. 1999).
Routine implementation faces operational obstacles
The reality, however, is that antenatal syphilis screening is
failing across sub-Saharan Africa. Based on the limited
coverage from 22 African countries (Gloyd et al. 2001), it
has been estimated that with these coverage levels and a
mean 8.3% prevalence of active syphilis, approximately
630 000 women are screened and treated while another
1 640 000 seropositive pregnant women remain untreated,
of whom 1 030 000 (63%) will have attended antenatal
services. Assuming RPR-positive women would have sim-
ilar rates of HTS as in Mwanza (27%) and that they would
experience a similar rate of adverse outcomes as observed
in untreated women in Mwanza (49%) (Watson-Jones
et al. 2002a), a total of 136 269 adverse birth outcomes
could potentially be averted by screening and treatment.
In principle, a single visit for on-site testing and same-
day treatment should improve the uptake of syphilis
screening (Watson-Jones et al. 2002a). This is important in
the context of sub-Saharan Africa where women frequently
fail to re-attend for treatment (Jenniskens et al. 1995;
Fonck et al. 2001). Despite the fact that Tanzania has
decided to implement a decentralised screening service,
however, a disappointingly low proportion of ANC
attenders are successfully screened and treated at PHC
level.
Screening and single-dose treatment are clinically
effective and cost-effective, and the procedures are simple,
implying that antenatal syphilis screening should be feas-
ible and affordable. What remain to be addressed,
however, are the operational barriers at the ANC level, as
well as the political will and financial constraints within
the health system.
Obstacles to successful implementation include the
organization of services, costs of treatment, transport costs
to health facilities performing testing and low priority at
government level (Gloyd et al. 2001), as well as staff
training, monitoring, quality control and logistics.
Improvements can be effective, as shown by an evaluation
of the antenatal syphilis screening programme in Nairobi,
which currently has a 3.4% RPR seroprevalence. Overall,
91% of RPR-positive women received prompt treatment
(Fonck et al. 2001). The programme started with an
intensive monitoring and evaluation phase in 1993 but,
over time, observed a decline in the quality of RPR testing
(Fonck et al. 2001). The authors concluded that main-
taining a high level of quality control and supervision was
Figure 2 Monthly rapid plasma reagin positivity rates among
antenatal clinic attenders over 4 months, in seven district facilities
implementing syphilis screening programme in Tanzania, 2000.
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difficult, and may be impossible in some remote settings,
and that in Nairobi mass treatment with penicillin in
pregnancy may be equally cost-effective. However, the
acceptability and effectiveness of this strategy are unpro-
ven.
Further research is needed on several specific compo-
nents of syphilis screening programmes. The simple and
cheap RPR test, recommended as a suitable screening test
for syphilis (World Health Organisation 2001; Centers for
Disease Control and Prevention 2002), is time-consuming,
subjective to interpret and therefore requires some experi-
ence to recognize a positive test. Although the RPR antigen
is relatively stable at room temperature (van Dyck et al.
2001), storage between 2 and 8 C is recommended, which
is difficult at the PHC level. It is unclear how much this
affects test performance as there are few sites implementing
regular quality control exercises. Our observations in
Tanzania also highlight the difficulties in ensuring that
HCW actually perform this test and show that there are
basic misunderstandings about the testing procedure. In
Nairobi, there was also wide variation in performance at
different clinics within the city (Jenniskens et al. 1995).
Wide variations are likely in other countries where
refresher training and quality assurance of programme
activities are infrequent.
There has long been an urgent need for simple rapid
screening tests for syphilis and other STI. Several dipstick-
type Treponema-specific serological tests for syphilis are
now on the market (Mabey and Peeling 2002). These new
tests, whose advantages and limitations are shown in
Table 3, could greatly simplify ANC syphilis screening,
because of their ease of use even under the most
rudimentary conditions. Like other Treponema-specific
tests, however, they do not distinguish between previously
treated and untreated infections and, in areas of high
syphilis prevalence, these tests may best be used in
conjunction with RPR results.
Treatment of sexual partners is a recommended com-
ponent of syphilis programmes in order to prevent
congenital syphilis because of maternal re-infection (World
Health Organization 2001; Centers for Disease Control
and Prevention 2002). The CE of this strategy has never
been rigorously evaluated in sub-Saharan Africa (Mathews
et al. 2001). First, there are few data on its actual efficacy.
One study in Nairobi found that RPR-positive women
whose partners attended for treatment had a better
pregnancy outcome than those whose partners did not
attend (Gichangi et al. 2000). However, this analysis was
not adjusted for other variables that might have influenced
birth outcome. Secondly, the effectiveness of the interven-
tion would depend on its coverage. In Tanzania, uptake of
treatment by partners has proved to be low (Watson-Jones
et al. 2002b), as in other countries where it varies between
15 and 75% (Jenniskens et al. 1995; Gichangi et al. 2000;
Fonck et al. 2001). Barriers to successful partner notifica-
tion in Africa include inadequate counselling, short-term or
casual relationships and fear of informing partners
(St Louis 1996; Fonck et al. 2001). Thirdly, doubts have
Table 3 Advantages and limitations of
Treponema-specific rapid diagnostic tests
for on-site antenatal syphilis screening
Advantages
Simplicity and speed (some tests can use whole blood rather then serum)
Reduces the time-consuming procedure of serum separation
Avoids 8-min shaking procedure required for RPR test
Shorter waiting time for patient to receive results
In most cases these tests are easier to read than agglutination tests
May reduce need for staff training and quality control that is essential to maintain
screening performance using subjective RPR test
Less subjective therefore improves the performance of on-site syphilis testing
Less expensive (Some tests can use a finger-prick specimen of capillary blood)
Lancets are cheaper than needle and syringes or vacutainer systems
No RPR test cards or test-tubes or racks required
Reagents can in most cases be stored at room temperature
Treatment costs for women with biological false positive RPR reactions would be
avoided
Limitations
Finger prick blood can be messy to handle
Patient’s preference for venous blood collection which appears more ‘serious’ in some
settings
Cannot distinguish between past and present infections
Lifetime positivity means difficulty in interpretation
in subsequent tests – may require ‘confirmatory’ RPR test
Cost of tests still high
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been raised as to whether partner notification has any
practical impact on syphilis transmission because those
most at risk of infection may not be traceable or may not
choose to attend for treatment (Andrus et al. 1990; St
Louis 1996). Certainly, both in Mwanza and South Africa
(Donders et al. 1997), over 60% of contacts presenting to
the clinic were syphilis seronegative. In our study, overall
42 of 203 (21%) attending male contacts with complete
serology results were RPR and TPHA positive. The rate of
seropositivity was significantly higher among partners of
women with HTS (32%), but a strategy targeting partners
of women with a confirmed RPR test (either HTS or LTS),
or indeed only women with HTS, would fail to identify a
high proportion of truly infected men: 7% (3/42) in the
former group, 62% (26/42) in the latter. In summary, there
are insufficient data from developing countries on the
quality of partner notification, the consequences for the
infected index case and their contacts, the CE and overall
impact on syphilis transmission of any contact tracing
strategy, but there is some evidence that it identifies a
significant number of men who otherwise would be left
untreated.
Despite these uncertainties, it is important that policy
makers and HCW recognize that syphilis screening is an
essential component of antenatal care. Moreover, we know
that syphilis is capable of re-emerging in populations
extremely rapidly when prevention efforts decline or
collapse (Nanda et al. 1990; Imperato 1991; Cossa et al.
1994; Borisenko et al. 1999). There is an array of cheap
and simple screening tests, an effective treatment, and the
cost per DALY saved is at least comparable with that of
HIV-PMTCT. Furthermore, there is evidence that antena-
tal syphilis screening may help to reduce the heterosexual
transmission of syphilis as the prevalence of syphilis is
declining in sites such as Nairobi where screening and
partner notification have been implemented for some years
(Temmerman et al. 1999).
Integration and sharing lessons learned
Syphilis screening as a routine antenatal intervention must
not be neglected in the context of initiatives to prevent
maternal transmission of HIV. Syphilis might not carry the
same stigma associated with HIV, given the relatively high
rate of women accepting the tests, and of their male
partners coming forward, and because syphilis is a curable
disease. Indeed, HIV surveillance and interventions have
often been piggy-backed onto antenatal syphilis screening
services. Conversely, efforts to provide wide-scale HIV-
PMTCT programmes would provide an excellent oppor-
tunity to strengthen antenatal syphilis screening. Both
interventions are aimed at the same target population, are
sited in the same facilities, face similar logistical challenges,
involve the same HCW and require a blood sample to be
taken after pre-test discussion. At present, however, HIV
prevention and treatment services are often organized
vertically, and this is likely to lead over time to increased
costs and fragmentation as observed in other vertical
programmes. The need to develop models of integration
must be addressed now, while PMTCT initiatives are still
in their developmental phase.
Studies in South Africa, Nairobi and Mwanza have
demonstrated that effective syphilis screening programmes
can be implemented through the PHC system if these
programmes are given sufficient support through training,
adequate supervision and availability of resources, and that
these programmes are capable of significantly reducing
adverse pregnancy outcomes attributable to syphilis
(Wilkinson & Sach 1998; Temmerman et al. 2000; Wat-
son-Jones et al. 2002b). Data on the implementation of
PMTCT programmes suggest that there are a number of
problems related to achieving coverage and retention of
patients, and that costs are much higher than in pilot or
trial conditions (Stringer et al. 2003). Experience from
syphilis screening also highlights the potential problems
faced by new PMTCT programmes as they try to increase
coverage. Adequate training, continuity of supplies of
testing kits, consumables and drugs, supervision and
quality control are all essential if the quality of the
intervention is to be sustained.
There is a need for genuine recognition by donors and
policy makers that syphilis control and PMTCT of HIV are
complementary. PMTCT programmes have a much larger
funding base and their system requirements are greater but
they will likely remain poorly implemented in areas where
there are currently no sustainable systems for syphilis
screening and management. PMTCT of HIV, maternal
syphilis screening and other ANC interventions would
benefit greatly from closer collaboration as part of an
integrated reproductive health programme. As govern-
ments grapple with decentralization of health services,
integration would help to ensure that evidence-based ANC
interventions such as syphilis screening, malarial prophy-
laxis and vitamin supplementation do not drop off the
agenda in the face of pressure to implement HIV-PMTCT
through vertical programmes.
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